The mild hypertension dilemma: results of the British MRC trial.
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001539:Bendroflumethiazide / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000209:etiology; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology; D003362:Cost-Benefit Analysis; D004739:England; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011897:Random Allocation; D012907:Smoking
D000959:Antihypertensive Agents; D001539:Bendroflumethiazide; D011433:Propranolol